The Breast Friends Podcast Ep. 7 | Dr. Daniel Hayes: The Future of Liquid Biopsy

How did liquid biopsy become one of the most important tools in modern oncology?In Episode 7 of The Breast Friends Podcast, Dr. Jason Mouabbi and Dr. Paolo Tarantino are joined by Dr. Daniel Hayes, Past President of ASCO and one of the pioneers behind tumor markers and liquid biopsy in breast cancer.From the mid-1980s breakthrough clinical discovery of CA 15-3 to the cutting-edge evolution of circulating tumor cells (CTCs), ctDNA, MRD, and multi-cancer early detection (MCED), Dr. Hayes shares the captivating behind-the-scenes stories, scientific milestones, and lessons that have shaped decades of breast cancer research.This conversation is more than an oncology history lesson. It's a deep dive into the future of precision medicine, the reality of tumor heterogeneity, and the mystery of cancer dormancy that will define the next generation of cancer care.🎙️ Hosted by Drs. Jason A. Mouabbi & Paolo Tarantino▶️ Watch on YouTube - https://youtu.be/PvguD4bXN-E🎧 Listen on Spotify, Apple Podcasts, iHeartRadio, CastBox, and Amazon Music - https://linkin.bio/breastfriendspodcast📺 As Mentioned in the Episode:Watch the historic interview featuring Dr. Daniel Hayes, Dr. Lawrence Einhorn, and John Cleland, the first patient ever cured of metastatic testicular cancer with platinum combination therapy: https://youtu.be/mKBQDSMInuI?si=YGvwlS-UfXlNvloPThe Breast Friends Podcast is part of the Community Health Media Podcast Network, where meaningful conversations help patients, caregivers, advocates, and healthcare professionals learn from one another, one story at a time.#BreastCancer #Oncology #LiquidBiopsy #ctDNA #CTCs #PrecisionOncology #CancerResearch #MedicalOncology #ASCO #OncologyPodcast #MedEd